Read More Pharma Industry News Merck licenses innovative anti-cancer therapy LM-299 from LaNova Medicines In a strategic move to broaden its oncology portfolio, Merck & Co., Inc. (NYSE: MRK), recognized globally as… byPallavi MadhirajuNovember 14, 2024